Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection.
Janssen HL, Lim YS, Kim HJ, Sowah L, Tseng CH, Coffin CS, Elkhashab M, Ahn SH, Nguyen AH, Chen D, Wallin JJ, Fletcher SP, McDonald C, Yang JC, Gaggar A, Brainard DM, Fung S, Kim YJ, Kao JH, Chuang WL, Brooks AE, Dunbar PR. Janssen HL, et al. JHEP Rep. 2023 Nov 30;6(2):100975. doi: 10.1016/j.jhepr.2023.100975. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38274492 Free PMC article.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B.
Chua C, Salimzadeh L, Ma AT, Adeyi OA, Seo H, Boukhaled GM, Mehrotra A, Patel A, Ferrando-Martinez S, Robbins SH, La D, Wong D, Janssen HLA, Brooks DG, Feld JJ, Gehring AJ. Chua C, et al. Hepatol Commun. 2023 Dec 7;7(12):e0337. doi: 10.1097/HC9.0000000000000337. eCollection 2023 Dec 1. Hepatol Commun. 2023. PMID: 38055623 Free PMC article.
Idiopathic Noncirrhotic Portal Hypertension.
Janssen HLA. Janssen HLA. Gastroenterol Hepatol (N Y). 2019 Jul;15(7):393-395. Gastroenterol Hepatol (N Y). 2019. PMID: 31391811 Free PMC article. No abstract available.
Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.
Patmore LA, Spaan M, Agarwal K, Koc ÖM, Blokzijl H, Brouwer S, van Soest H, van Hulzen AGW, Janssen HLA, Lammers AJJ, Jansen L, Claassen M, de Man RA, Takkenberg RB, van Dijk R, Posthouwer D, Reijnders JGP, Carey I, Sonneveld MJ. Patmore LA, et al. Among authors: janssen hla. Clin Gastroenterol Hepatol. 2024 Oct 9:S1542-3565(24)00868-1. doi: 10.1016/j.cgh.2024.08.036. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39384029 Free article.
EASL Clinical Practice Guidelines: Vascular diseases of the liver.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. 2016 Jan;64(1):179-202. doi: 10.1016/j.jhep.2015.07.040. Epub 2015 Oct 26. J Hepatol. 2016. PMID: 26516032 No abstract available.
Combination Therapy for Chronic HBV Infection.
Janssen HLA, Sonneveld MJ. Janssen HLA, et al. N Engl J Med. 2024 Dec 5;391(22):2163-2168. doi: 10.1056/NEJMe2410543. N Engl J Med. 2024. PMID: 39774318 No abstract available.
637 results